
Autoimmune conditions occur when the immune system mistakenly attacks the body's own tissues, leading to chronic inflammation, tissue damage, and systemic dysfunction. These conditions affect millions worldwide and can significantly impact daily functioning and quality of life.
Common autoimmune conditions include rheumatoid arthritis, lupus, multiple sclerosis, inflammatory bowel disease, psoriasis, and Hashimoto's thyroiditis. Symptoms vary widely but often include fatigue, pain, inflammation, and organ-specific dysfunction.
Mesenchymal stem cells possess powerful immunomodulatory properties that can help rebalance an overactive immune system without suppressing it entirely.
MSCs modulate both innate and adaptive immune responses, helping to restore balance between pro-inflammatory and anti-inflammatory signals.
Stem cells release anti-inflammatory cytokines that dampen the chronic inflammatory cascade characteristic of autoimmune conditions.
MSCs can migrate to sites of tissue damage, releasing growth factors that support repair and protect against further immune-mediated damage.
Emerging research suggests MSCs may help restore gut barrier function and microbiome balance, addressing a root cause of many autoimmune conditions.
Detailed immune panel, inflammatory markers, and functional medicine evaluation to understand your unique autoimmune profile.
Intravenous or targeted injection of high-dose MSCs, often combined with supportive therapies to optimize immune function.
Nutritional protocols, gut health optimization, stress management, and regular monitoring of immune markers.
Autoimmune conditions are complex and highly individual. While stem cell therapy shows promise in modulating immune function, outcomes depend on condition severity, duration, and overall health status.
Many patients experience fewer and less severe autoimmune flares, with longer periods of remission.
Reduction in chronic fatigue as systemic inflammation decreases and cellular function improves.
Some patients successfully reduce immunosuppressive medications under medical supervision as symptoms improve.
Improved ability to engage in daily activities, work, and social interactions without debilitating symptoms.
Measurable decreases in inflammatory markers (CRP, ESR, cytokines) indicating improved immune regulation.
Protection and potential improvement in organ function affected by autoimmune attack.